Concepedia

Kirstine Brown‐Frandsen

KB

Statistics

Publications

6

Citations

3.5K

H-Index

6

Active since

2020

Affiliations

University College London(Current)

The University of Texas Southwestern Medical Center

University of Washington

Novo Nordisk (Denmark)

Harvard University

Kirstine Brown‐Frandsen is an author at University College London specializing in cardiovascular pharmacotherapy, pharmacotherapy, and cardiovascular disease.

Publications per year

2020–2025

6

Publications

6

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.6K citations · Full text

, , +17

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh et al. · New England Journal of Medicine · 2025 · 301 citations · Full text

, , +17

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

Donna H. Ryan, Ildiko Lingvay, Helen M. Colhoun et al. · American Heart Journal · 2020 · 239 citations · Full text

, , +17

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Helen M. Colhoun, Ildiko Lingvay, Paul Brown et al. · Nature Medicine · 2024 · 197 citations · Full text

, , +16

Semaglutide for cardiovascular event reduction in people with overweight or obesity: <scp>SELECT</scp> study baseline characteristics

Ildiko Lingvay, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · Obesity · 2022 · 102 citations · Full text

, , +13

1–5 of 6